Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. Its compounds include brincidofovir (BCV, CMX001).
Our STA Research today shows that the stock is due for a 98% increase in it’s stock valuation within a 6 to 12 month duration.  Yahoo Finance Analyst Report indicates a 27% increase. Our STA Research rating indicates the stock a Buy with Bearish near term sentiment.
| AVG Analyst Rating | STA Analysis | |
|---|---|---|
Strong Buy
|
Slightly Bullish
|
|
Strong Buy
|
Slightly Bearish
|
|
| N/A |
Bearish
|
|
Strong Buy
|
Slightly Bullish
|
|
| N/A |
Bullish
|
|
| N/A |
Slightly Bullish
|
|
| N/A |
Bearish
|
|
|
Buy
|
Neutral
|
|
Hold
|
Slightly Bearish
|
|
| N/A |
Bullish
|
Do not have an account? Register here
